This Report features up to a ten-year record of the equity Price history for Galapagos Genomics. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Galapagos Genomics. The Group's principal activity is to discover, develop and sell drugs. The Group specializes in developing drugs for bone and joint diseases such as osteoarthritis, osteoporosis and rheumatoid arthritis. The Group also offers services to pharmaceutical and biotech companies such as encompassing target discovery to validation and drug discovery services through to delivery of pre-clinical candidates. The Group also works in partnership with some major pharmaceutical and biotechnology companies such as Amgen, GlaxoSmithKline, Novartis and Wyeth. The Group operates mainly in Belgium, Netherlands, France, the United Kingdom and the United States.
Not the Report you are looking for?Click here for more browsing options.
* If a currency is not selected, the report will be delivered in the local currency of the company ** Full access limits users to 500 reports per month
Web site and selected data copyright 2008 The Winthrop Corporation. All rights reserved. Selected data copyright 2008, "Worldscope/Disclosure, L.L.C., a Primark affiliate." All rights reserved.
